Testing drug sensitivity in solid tumors using needle biopsies.
MetaboCore: Needle biopsy assay of drug sensitivity for solid tumors.
This study is testing a new way to help doctors find the best cancer treatments for patients by looking at how their tumors respond to different drugs using fresh samples, so they can get quicker and more personalized care.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-10858769 on NIH RePORTER |
What this research studies
This research focuses on improving personalized cancer treatment by developing a new assay that evaluates how sensitive a patient's tumor is to various drugs. Using fresh tumor tissues obtained through needle biopsies, the MetaboCore assay measures metabolic changes in cancer cells shortly after drug exposure. This approach aims to provide oncologists with quick and reliable results, allowing for more tailored treatment options for patients. The research will also establish standardized procedures to ensure consistent and reproducible outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with solid tumors who are undergoing needle biopsy procedures.
Not a fit: Patients with blood cancers or those who are not undergoing biopsy procedures may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to faster and more effective cancer treatments tailored to individual patients' tumors.
How similar studies have performed: Previous research has shown promise in using metabolic assays for drug sensitivity testing, but this specific approach is novel and aims to overcome existing limitations.
Where this research is happening
Seattle, United States
- University of Washington — Seattle, United States (Active)
Researchers
- Principal investigator: Yeung, Raymond — University of Washington
- Study coordinator: Yeung, Raymond
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.